These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 207494)

  • 1. A hundred years of the hepatotrophic controversy.
    Starzl TE; Porter KA; Francavilla JA; Benichou J; Putnam CW
    Ciba Found Symp; 1977; (55):111-29. PubMed ID: 207494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs.
    Starzl TE; Porter KA; Kashiwagi N; Lee IY; Russsell WJ; Putnam CW
    Surg Gynecol Obstet; 1975 Apr; 140(4):549-62. PubMed ID: 18689029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration.
    Starzl TE; Porter KA; Kashiwagi N
    Surg Gynecol Obstet; 1975 Dec; 141(6):843-58. PubMed ID: 1188560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons.
    Starzl TE; Lee IY; Porter KA; Putnam CW
    Surg Gynecol Obstet; 1975 Mar; 140(3):381- 96. PubMed ID: 18689027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.
    Starzl TE; Watanabe K; Porter KA; Putnam CW
    Lancet; 1976 Apr; 1(7964):821-5. PubMed ID: 56646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood.
    Starzl TE; Francavilla A; Halgrimson CG; Francavilla FR; Porter KA; Brown TH; Putnam CW
    Surg Gynecol Obstet; 1973 Aug; 137(2):179-99. PubMed ID: 4353133
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula.
    Francavilla A; Starzl TE; Porter K; Foglieni CS; Michalopoulos GK; Carrieri G; Trejo J; Azzarone A; Barone M; Zeng QH
    Hepatology; 1991 Oct; 14(4 Pt 1):665-70. PubMed ID: 1916668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of splanchnic viscera removal upon canine liver regeneration.
    Starzl TE; Francavilla A; Porter KA; Benichou J; Jones AF
    Surg Gynecol Obstet; 1978 Aug; 147(2):193-207. PubMed ID: 210529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotrophic substances.
    Starzl TE; Terblanche J
    Prog Liver Dis; 1979; 6():135-51. PubMed ID: 396553
    [No Abstract]   [Full Text] [Related]  

  • 10. Other views about the hepatotrophic concept.
    Weinbren K
    Ciba Found Symp; 1977; (55):139-43. PubMed ID: 247998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of animals maintained without splanchnic portal organs.
    Price JB; Takeshige K; Parsa M; Voorhees AB
    Surgery; 1971 Nov; 70(5):768-77. PubMed ID: 5001036
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect upon the liver of evisceration with or without hormone replacement.
    Starzl TE; Francavilla A; Porter KA; Benichou J
    Surg Gynecol Obstet; 1978 Apr; 146(4):524-32. PubMed ID: 205003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension.
    Zhang ZT; Jiang P; Wang Y; Li JS; Xue JG; Zhou YZ; Yuan Z
    Chin Med J (Engl); 2006 Oct; 119(20):1727-33. PubMed ID: 17097021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver regeneration after portacaval transportation in rats.
    Lee S; Broelsch CE; Flamant YM; Chandler JG; Charters AC; Orloff MJ
    Surgery; 1975 Jan; 77(1):144-9. PubMed ID: 1109514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon as the portal factor modifying hepatic regeneration.
    Price JB; Takeshige K; Max MH; Voorhees AB
    Surgery; 1972 Jul; 72(1):74-82. PubMed ID: 5033194
    [No Abstract]   [Full Text] [Related]  

  • 16. The Eck fistula in animals and humans.
    Starzl TE; Porter KA; Francavilla A
    Curr Probl Surg; 1983 Nov; 20(11):687-752. PubMed ID: 6357642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both positive and negative portal venous and hepatic arterial glucose gradients stimulate hepatic glucose uptake after the same amount of glucose is infused into the splanchnic bed in conscious dogs.
    Horikawa S; Ishida T; Igawa K; Kawanishi K; Hartley CJ; Takahara J
    Metabolism; 1998 Nov; 47(11):1295-302. PubMed ID: 9826203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.
    Galassetti P; Shiota M; Zinker BA; Wasserman DH; Cherrington AD
    Am J Physiol; 1998 Jul; 275(1):E101-11. PubMed ID: 9688880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic regeneration in the absence of portal viscera.
    Whittemore AD; Kasuya M; Voorhees AB; Price JB
    Surgery; 1975 Mar; 77(3):419-26. PubMed ID: 1124497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon.
    Bucher ML; Swaffield MN
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):1157-60. PubMed ID: 1055372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.